COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

19/09/2024 - 13:00

LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and [...]

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease

19/09/2024 - 13:00

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor

19/09/2024 - 13:00

Press Release Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision biotech company dedicated to [...]

BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs

19/09/2024 - 12:55

MELVILLE, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell- [...]

ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City

19/09/2024 - 11:22

Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor conferences in New [...]

LinkGevity Awarded Deep-Tech EU Grant

19/09/2024 - 10:00

Sisters Leading the Charge in AI-Driven Drug Discovery: Transforming the Future of Age-Related Disease Treatment LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LinkGevity, an AI-driven drug discovery company focused on [...]

SAFE - Réduction du capital social de la Société

19/09/2024 - 08:00

Réduction du capital social de la Société Fleurieux-sur-l’Arbresle - France - le 19 septembre 2024 à 8h . Safe (FR001400RKU0 - ALSAF) (la « Société ») annonce que consécutivement au regroupement des actions qui a eu [...]

ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière

19/09/2024 - 07:30

La société poursuit ses recherches novatrices sur un système activé par une interface cerveau-machine (BCI) pour restaurer la mobilité après une lésion de la moelle épinière EINDHOVEN, Pays-Bas, 19 sept. 2024 (GLOBE [...]

ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury

19/09/2024 - 07:30

Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injury EINDHOVEN, The Netherlands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical [...]

Basilea enters into agreement with BARDA to develop novel antifungals and antibacterials and receives initial funding

19/09/2024 - 07:15

Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix and BAL2062 Multi-year Other Transaction Agreement (OTA) allows for potential funding of up [...]

U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates

19/09/2024 - 07:00

London (UK), September 19 2024 – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments [...]

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

19/09/2024 - 07:00

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART ® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced risk of relapse and [...]

Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses

19/09/2024 - 07:00

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members This is the first time that any antiviral used in the treatment of a respiratory [...]

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

19/09/2024 - 07:00

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]

Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I

19/09/2024 - 00:30

PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I (“Achari”) to terminate the Business [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18/09/2024 - 23:00

NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18/09/2024 - 23:00

Industry Leaders to Explore Cytek’s Advanced Cell Analysis Solutions at ICCS and ESCCA FREMONT, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) is set to elevate its presence at this [...]

Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024

18/09/2024 - 23:00

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through [...]

ARCPOINT ADDS FUNCTIONALITY TO ENABLE TELEHEALTH PRACTITIONERS TO ORDER DIAGNOTIC TESTS THROUGH ARCPOINT SYSTEM

18/09/2024 - 22:35

Greenville, South Carolina, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to report that it has implemented an integration that allows telehealth doctors and [...]